 | • レポートコード：D0JU09118 • 出版社/出版日：Transparency Market Research / 2020年2月7日 • レポート形態：英文、PDF、195ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、プラークモディフィケーション装置の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、製品種類別（アテレクトミーデバイス、血栓切除デバイス、慢性完全閉塞（CTO）デバイス、塞栓予防デバイス（EPD））分析、用途別（冠動脈疾患、末梢動脈疾患、神経血管疾患、その他）分析、エンドユーザー別（病院、専門クリニック、外来手術センター）分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・プラークモディフィケーション装置の世界市場：製品種類別（アテレクトミーデバイス、血栓切除デバイス、慢性完全閉塞（CTO）デバイス、塞栓予防デバイス（EPD）） ・プラークモディフィケーション装置の世界市場：用途別（冠動脈疾患、末梢動脈疾患、神経血管疾患、その他） ・プラークモディフィケーション装置の世界市場：エンドユーザー別（病院、専門クリニック、外来手術センター） ・プラークモディフィケーション装置の世界市場：地域別 ・競争状況 |
Plaque Modification Devices Market – Scope of the Report
TMR’s report on the global plaque modification devices market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2019 to 2027. The report provides the overall revenue of the global plaque modification devices market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global plaque modification devices market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global plaque modification devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global plaque modification devices market.
The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global plaque modification devices market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global plaque modification devices market. The next section of the global plaque modification devices market report highlights the USPs, which include technological advancements, reimbursement scenario, prevalence of atherosclerosis, and increase in incidence of coronary & peripheral artery diseases and hypertension in the global plaque modification devices market.
The report delves into the competitive landscape of the global plaque modification devices market. Key players operating in the global plaque modification devices market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global plaque modification devices market report.
Key Questions Answered in Global Plaque Modification Devices Market Report
What is the sales/revenue generated by the global plaque modification devices market across all the regions during the forecast period?
What are the key trends in the global plaque modification devices market?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which product type will expand at the fastest CAGR during the forecast period?
Plaque Modification Devices Market – Research Objectives and Research Approach
The comprehensive report on the global plaque modification devices market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global plaque modification devices market. It is followed by market introduction, market dynamics, and an overview of the global plaque modification devices market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the plaque modification devices market. The next section of the global plaque modification devices market report highlights the USPs, which include atherosclerosis, coronary & peripheral artery disease prevalence & incidence globally, reimbursement scenarios and technological advancements in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key plaque modification device manufacturers has been mapped to ascertain the size of the global plaque modification devices market in terms of value. The forecast presented here assesses the total revenue generated in the plaque modification devices market. In order to provide an accurate forecast, we initiated by sizing up the current plaque modification devices market with the help of the parent market.
The report analyzes the global plaque modification devices market in terms of product type, application, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global plaque modification devices market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Plaque Modification Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Plaque Modification Devices Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with Key countries
5.3. Reimbursement Scenario, by Region/globally
5.4. Growing Minimal Invasive Surgeries
6. Global Plaque Modification Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
6.3.1. Atherectomy Devices
6.3.2. Thrombectomy Devices
6.3.3. Chronic Total Occlusion (CTO) Devices
6.3.4. Embolic Protection Devices (EPD)
6.4. Market Attractiveness Analysis, by Product Type
7. Global Plaque Modification Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Plaque Modification Devices Market Value Forecast, by Application, 2017–2027
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Artery Disease
7.3.3. Neurovascular Disease
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Plaque Modification Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Plaque Modification Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Plaque Modification Devices Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Plaque Modification Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
10.2.1. Atherectomy Devices
10.2.2. Thrombectomy Devices
10.2.3. Chronic Total Occlusion (CTO) Devices
10.2.4. Embolic Protection Devices (EPD)
10.3. North America Plaque Modification Devices Market Value Forecast, by Application , 2017–2027
10.3.1. Coronary Artery Disease
10.3.2. Peripheral Artery Disease
10.3.3. Neurovascular Disease
10.3.4. Others
10.4. North America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Ambulatory Surgical Centers
10.5. North America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Plaque Modification Devices Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Plaque Modification Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
11.2.1. Atherectomy Devices
11.2.2. Thrombectomy Devices
11.2.3. Chronic Total Occlusion (CTO) Devices
11.2.4. Embolic Protection Devices (EPD)
11.3. Europe Plaque Modification Devices Market Value Forecast, by Application, 2017–2027
11.3.1. Coronary Artery Disease
11.3.2. Peripheral Artery Disease
11.3.3. Neurovascular Disease
11.3.4. Others
11.4. Europe Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Europe Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Plaque Modification Devices Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Plaque Modification Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
12.2.1. Atherectomy Devices
12.2.2. Thrombectomy Devices
12.2.3. Chronic Total Occlusion (CTO) Devices
12.2.4. Embolic Protection Devices (EPD)
12.3. Asia Pacific Plaque Modification Devices Market Value Forecast, by Application, 2017–2027
12.3.1. Coronary Artery Disease
12.3.2. Peripheral Artery Disease
12.3.3. Neurovascular Disease
12.3.4. Others
12.4. Asia Pacific Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Asia Pacific Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Plaque Modification Devices Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Plaque Modification Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
13.2.1. Atherectomy Devices
13.2.2. Thrombectomy Devices
13.2.3. Chronic Total Occlusion (CTO) Devices
13.2.4. Embolic Protection Devices (EPD)
13.3. Latin America Plaque Modification Devices Market Value Forecast, by Application, 2017–2027
13.3.1. Coronary Artery Disease
13.3.2. Peripheral Artery Disease
13.3.3. Neurovascular Disease
13.3.4. Others
13.4. Latin America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Latin America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Plaque Modification Devices Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Plaque Modification Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027
14.2.1. Atherectomy Devices
14.2.2. Thrombectomy Devices
14.2.3. Chronic Total Occlusion (CTO) Devices
14.2.4. Embolic Protection Devices (EPD)
14.3. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Application, 2017–2027
14.3.1. Coronary Artery Disease
14.3.2. Peripheral Artery Disease
14.3.3. Neurovascular Disease
14.3.4. Others
14.4. Middle East & Africa Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Ambulatory Surgical Centers
14.5. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Boston Scientific Corporation
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Strategic Overview
15.2.1.5. SWOT Analysis
15.2.2. B. Braun Melsungen
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Strategic Overview
15.2.2.5. SWOT Analysis
15.2.3. Becton, Dickinson and Company
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. Cardinal Health
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Medtronic
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Cardiovascular Systems, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Microvention, Inc. (Terumo)
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Strategic Overview
15.2.7.5. SWOT Analysis
15.2.8. Penumbra, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. Biotronik
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Stryker
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. Codman Neuro (Johnson & Johnson)
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Financial Overview
15.2.11.3. Product Portfolio
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
List of TablesTable 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 04: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 05: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 07: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 08: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 09: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 12: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 13: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 14: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 17: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 18: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 20: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 22: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 23: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 27: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 28: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 29: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 30: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027